Skip to main content
. 2020 Sep 17;10:15286. doi: 10.1038/s41598-020-71857-3

Figure 5.

Figure 5

GSC viability following Ccl2 silencing. (a) Ccl2 mRNA levels in GSCs transfected with 10 nM Ccl2 siRNA (siCcl2) or negative control siRNA (siCon) for 24 h (n = 6). (b) Representative western blot results for CCL2 (n = 4). (c) Representative western blot results for cyclin D1 from GSCs at 48-h post-transfection with siCcl2 or siCon (n = 4). (d) Representative images of GSCs and cell viability evaluated by WST-8 assay at 48-h post-transfection with siCcl2 or siCon (n = 4). Scale bar, 50 µm. (e) Schematic illustration of the antitumor effects of celecoxib in the mouse glioma model. Data represent the mean ± SD. *p < 0.05, **p < 0.01 vs. siCon by Student’s t test.